SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'IXO'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RZE_A_D7VA1201_1 (HISTAMINE H1RECEPTOR, LYSOZYMECHIMERA) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104SER A 107TRP A 155TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)IXO A 501 (-4.6A) | 1.08A | 3rzeA-4mqtA:29.4 | 3rzeA-4mqtA:28.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RZE_A_D7VA1201_1 (HISTAMINE H1RECEPTOR, LYSOZYMECHIMERA) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104SER A 107TRP A 155TYR A 430 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)IXO A 501 (-4.5A) | 0.81A | 3rzeA-4mqtA:29.4 | 3rzeA-4mqtA:28.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108THR A 187ALA A 194TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneIXO A 501 (-3.5A)IXO A 501 (-4.6A) | 1.25A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108THR A 187ALA A 194TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A) | 0.90A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.28A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 0.87A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ALA A 194ASN A 404TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 0.91A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.16A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108ALA A 194TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.5A)IXO A 501 (-4.6A) | 1.12A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108ALA A 194TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.5A)2CU A 502 ( 3.9A) | 0.85A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)IXO A 501 (-4.6A) | 1.06A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)2CU A 502 ( 3.9A) | 0.74A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107TRP A 155TRP A 400CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)IXO A 501 (-4.6A)IXO A 501 (-3.5A) | 1.17A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107TRP A 155TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.98A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107TRP A 400TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 1.20A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.06A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ALA A 194ASN A 404TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 0.93A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.22A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104THR A 187TRP A 400TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 1.20A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104THR A 187TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.04A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.28A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104TRP A 155THR A 187TRP A 400CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A)IXO A 501 (-3.5A) | 1.25A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104TRP A 155THR A 187TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.02A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | TYR A 104SER A 107ASN A 108TRP A 155TYR A 426 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)2CU A 502 ( 3.9A) | 1.19A | 4dajA-4mqtA:32.7 | 4dajA-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103SER A 107TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.38A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103SER A 107TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.06A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103THR A 187THR A 190TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.24A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103THR A 187THR A 190TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.93A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ALA A 194ASN A 404TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 0.97A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.27A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.97A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.20A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.38A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104THR A 187THR A 190ALA A 194ASN A 404TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 0.93A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104THR A 187THR A 190ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.21A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104THR A 187THR A 190ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.81A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 1.09A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104TRP A 155THR A 187TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.32A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_B_0HKB2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104TRP A 155THR A 187TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 0.91A | 4dajB-4mqtA:32.3 | 4dajB-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103ASN A 108THR A 187THR A 190ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.93A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103ASN A 108THR A 187THR A 190TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.24A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103SER A 107ASN A 108ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.01A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103SER A 107TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.41A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103SER A 107TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.10A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103THR A 187ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.50A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103THR A 187THR A 190TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.31A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103THR A 187THR A 190TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.03A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103THR A 190TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.4A)NoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 1.26A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108THR A 187THR A 190TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-4.6A) | 1.10A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104ASN A 108THR A 187THR A 190TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.84A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.28A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 0.93A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-4.6A) | 1.12A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.86A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_C_0HKC2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104THR A 187TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.19A | 4dajC-4mqtA:25.8 | 4dajC-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103SER A 107TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.29A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103SER A 107TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.08A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103THR A 187THR A 190TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.23A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103THR A 187THR A 190TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.03A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103THR A 190TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.4A)NoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 1.29A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | ASP A 103TYR A 104ASN A 108THR A 187THR A 190ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.95A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104ASN A 108THR A 187THR A 190TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.15A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.23A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104ASN A 108TRP A 155THR A 187TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.98A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107ASN A 108ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.96A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)IXO A 501 (-4.6A) | 1.06A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 155TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-3.6A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.91A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ASN A 108TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-4.3A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.15A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4DAJ_D_0HKD2000_1 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.48A | 4dajD-4mqtA:33.1 | 4dajD-4mqtA:44.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NC3_A_ERMA1202_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | LEU A 100ASP A 103SER A 107ALA A 194TRP A 400 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-4.6A) | 0.57A | 4nc3A-4mqtA:29.2 | 4nc3A-4mqtA:28.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.17A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ALA A 191ALA A 194TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A) | 0.99A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107ALA A 191ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.99A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107ALA A 191TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.23A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 1.13A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ILE A 72ASP A 103TYR A 104THR A 187ALA A 191ALA A 194TYR A 426 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A) | 0.98A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | ILE A 72ASP A 103TYR A 104THR A 187ALA A 191ASN A 404TYR A 426CYH A 429 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.89A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ILE A 72ASP A 103TYR A 104THR A 187ALA A 191TRP A 400ASN A 404 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.13A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ILE A 72ASP A 103TYR A 104TRP A 155THR A 187TRP A 400 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.34A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U14_A_0HKA2000_1 (MUSCARINICACETYLCHOLINERECEPTORM3,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ILE A 72ASP A 103TYR A 104TRP A 155THR A 187TYR A 426 | NoneIXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A) | 1.03A | 4u14A-4mqtA:33.1 | 4u14A-4mqtA:45.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 9 / 12 | ASP A 103TYR A 104SER A 107THR A 187THR A 190ALA A 191ALA A 194ASN A 404TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneNoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 0.95A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 9 / 12 | ASP A 103TYR A 104SER A 107THR A 187THR A 190ALA A 191ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneNoneIXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.13A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 9 / 12 | ASP A 103TYR A 104SER A 107THR A 187THR A 190ALA A 191ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneNoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.87A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107TRP A 155THR A 187TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)NoneIXO A 501 (-4.6A) | 1.28A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107TRP A 155THR A 187TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.02A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.18A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneIXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.39A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_A_0HKA2001_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.38A | 4u15A-4mqtA:33.3 | 4u15A-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107THR A 190ALA A 191ALA A 194TRP A 400 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-4.6A) | 1.09A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | ASP A 103TYR A 104SER A 107THR A 190ALA A 191ALA A 194TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.88A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | ASP A 103TYR A 104SER A 107THR A 190ALA A 191TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.14A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 9 / 12 | ASP A 103TYR A 104SER A 107THR A 190ALA A 191TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.98A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.21A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104THR A 187THR A 190ALA A 191ALA A 194CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneNoneIXO A 501 (-3.5A)IXO A 501 (-3.5A) | 0.90A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | ASP A 103TYR A 104THR A 187THR A 190ALA A 191TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 0.96A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4U15_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM3,LYSOZYME,MUSCARINIC ACETYLCHOLINERECEPTOR M3) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | THR A 187THR A 190ALA A 191ALA A 193TYR A 403 | NoneNoneNoneNoneIXO A 501 (-3.8A) | 1.38A | 4u15B-4mqtA:33.6 | 4u15B-4mqtA:49.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | ASP A 103TYR A 104SER A 107ALA A 191ALA A 194ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.79A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107ALA A 191TRP A 400ASN A 404TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-4.6A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 0.90A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107TRP A 155ALA A 194TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)IXO A 501 (-3.5A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.75A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104SER A 107TRP A 155TRP A 400TYR A 426 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)IXO A 501 (-4.6A)2CU A 502 ( 3.9A) | 0.93A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.36A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107ALA A 191TRP A 400TYR A 403ASN A 404TYR A 426 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A) | 1.07A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CXV_A_0HKA501_1 (MUSCARINICACETYLCHOLINERECEPTORM1,ENDOLYSIN,MUSCARINIC ACETYLCHOLINERECEPTOR M1) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107ALA A 191TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.90A | 5cxvA-4mqtA:32.6 | 5cxvA-4mqtA:41.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107THR A 187THR A 190TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.87A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | ASP A 103TYR A 104SER A 107TRP A 155THR A 187TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.01A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104THR A 187ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.30A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | ASP A 103TYR A 104TRP A 155ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.4A)IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.45A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | TYR A 104SER A 107THR A 187THR A 190ALA A 194ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.81A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 187THR A 190ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.00A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 187THR A 190TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.12A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 8 / 12 | TYR A 104SER A 107THR A 187THR A 190TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.94A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | TYR A 104SER A 107TRP A 155THR A 187ALA A 194TRP A 400 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)NoneIXO A 501 (-3.5A)IXO A 501 (-4.6A) | 1.13A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_A_0HKA1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107TRP A 155THR A 187ALA A 194TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)NoneIXO A 501 (-3.5A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.93A | 5dsgA-4mqtA:32.8 | 5dsgA-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 187THR A 190ALA A 194ASN A 404CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 0.77A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 187THR A 190ALA A 194TRP A 400ASN A 404 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.5A)IXO A 501 (-4.6A)IXO A 501 (-3.0A) | 1.00A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 187THR A 190TRP A 400TYR A 403ASN A 404 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-4.6A)IXO A 501 (-3.8A)IXO A 501 (-3.0A) | 1.11A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 187THR A 190TYR A 403ASN A 404CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneNoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)IXO A 501 (-3.5A) | 0.91A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 190ALA A 194ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.5A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.70A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 7 / 12 | TYR A 104SER A 107THR A 190TYR A 403ASN A 404TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)NoneIXO A 501 (-3.8A)IXO A 501 (-3.0A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.87A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | TYR A 104SER A 107TRP A 155ALA A 194TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)IXO A 501 (-3.5A)2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 0.74A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | TYR A 104SER A 107TRP A 155THR A 187ALA A 194CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)NoneIXO A 501 (-3.5A)IXO A 501 (-3.5A) | 0.93A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 6 / 12 | TYR A 104SER A 107TRP A 155THR A 187ALA A 194TRP A 400 | IXO A 501 (-3.7A)IXO A 501 (-3.4A)IXO A 501 (-3.6A)NoneIXO A 501 (-3.5A)IXO A 501 (-4.6A) | 1.15A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | TYR A 104THR A 187ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.7A)NoneNone2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.28A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_1 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | TYR A 104TRP A 155ALA A 191TYR A 426CYH A 429 | IXO A 501 (-3.7A)IXO A 501 (-3.6A)None2CU A 502 ( 3.9A)IXO A 501 (-3.5A) | 1.44A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5DSG_B_0HKB1201_2 (MUSCARINICACETYLCHOLINERECEPTORM4,ENDOLYSIN,ENDOLYSIN,MUSCARINICACETYLCHOLINERECEPTOR M4) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 3 / 3 | ASP A 103ASN A 108PHE A 195 | IXO A 501 (-3.4A)IXO A 501 (-4.3A)None | 0.78A | 5dsgB-4mqtA:33.7 | 5dsgB-4mqtA:60.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CNK_B_NCTB402_1 (NEURONALACETYLCHOLINERECEPTOR SUBUNITALPHA-4NEURONALACETYLCHOLINERECEPTOR SUBUNITBETA-2) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 4 / 7 | TYR A 430TYR A 403TRP A 99LEU A 100 | IXO A 501 (-4.5A)IXO A 501 (-3.8A)NoneNone | 1.49A | 6cnkB-4mqtA:undetectable6cnkC-4mqtA:undetectable | 6cnkB-4mqtA:12.466cnkC-4mqtA:11.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DRX_A_H8GA1201_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | TRP A 99LEU A 100SER A 107ALA A 194TRP A 400 | NoneNoneIXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-4.6A) | 0.60A | 6drxA-4mqtA:29.0 | 6drxA-4mqtA:27.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DRX_A_H8GA1201_0 (5HT2B RECEPTOR, BRILCHIMERA) |
4mqt | MUSCARINICACETYLCHOLINERECEPTOR M2 (Homosapiens) | 5 / 12 | TRP A 99LEU A 100SER A 107ALA A 194TYR A 430 | NoneNoneIXO A 501 (-3.4A)IXO A 501 (-3.5A)IXO A 501 (-4.5A) | 0.76A | 6drxA-4mqtA:29.0 | 6drxA-4mqtA:27.42 |